OBIZUR
Antihemophilic Factor (Recombinant), Porcine Sequence · KIT · Takeda Pharmaceuticals America, Inc.
Obizur is a recombinant antihemophilic factor used to treat bleeding episodes in patients with hemophilia A who have developed inhibitors to human factor VIII. It comes as a kit for injection and is available over-the-counter.
Key Facts
- Brand Name
- OBIZUR
- Generic Name
- Antihemophilic Factor (Recombinant), Porcine Sequence
- NDC Code (Product)
0944-5001- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125512
- Marketing Start
- 10/23/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is OBIZUR used for?
Obizur is a recombinant antihemophilic factor used to treat bleeding episodes in patients with hemophilia A who have developed inhibitors to human factor VIII. It comes as a kit for injection and is available over-the-counter.
Is OBIZUR a controlled substance?
OBIZUR is not classified as a controlled substance by the DEA.
What is the generic name for OBIZUR?
The generic name for OBIZUR is Antihemophilic Factor (Recombinant), Porcine Sequence. There are no other listed brand versions of Antihemophilic Factor (Recombinant), Porcine Sequence.
What is the NDC code for OBIZUR ?
The NDC (National Drug Code) for OBIZUR is 0944-5001, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)